Metastatic Non Small Cell Lung Cancer trials recruiting in Washington
All Metastatic Non Small Cell Lung Cancer trials nationally
7
Recruiting in Washington
8
Cities with sites
Cities in Washington
Seattle 3Vancouver 2Auburn 1Edmonds 1Gig Harbor 1Puyallup 1Spokane 1Tacoma 1
Recruiting trials in Washington
- A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer